Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05293340 · ClinicalTrials.gov registry record · NA
Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")
A NA study, sponsored by Sansum Diabetes Research Institute.
- Terminated
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT05293340: Clinical Trial NA study, sponsored by Sansum Diabetes Research Institute.
NCT05293340 is a NA study that was terminated before completion, run by Sansum Diabetes Research Institute. The registered enrollment target is 50 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05293340, a NA study, was terminated before completion, sponsored by Sansum Diabetes Research Institute.
- TERMINATED
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
Hispanic/Latino adults in the United States (U.S.) bear a disproportionate burden of type 2 diabetes (T2D). Dietary changes, facilitated by increased access and adherence to healthy foods, are necessary. In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic control in Hispanic/Latino (predominantly of Mexican origin) adults with or at-risk of T2D before and after receiving free avocados for 12 weeks. Beyond CGM-measured glycemic control, wearable activity and sleep monitors, physical exams, laboratory analyses, and questionnaires/logs will be used to track the impact of free avocado vouchers. The findings are anticipated to help clinicians provide new information to support positive behavior change to reduce the risk of T2D or progression from pre-diabetes to T2D and make it easier for patients to access healthier food, potentially leading to improved health.
Primary Outcome
TIR (140 -180 mg/dL) between 6 am and 12 am (waking hours).
Interventions
- DIETARY_SUPPLEMENT Avocado Vouchers
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-03-31 |
| Est. Completion | 2023-01-31 |
| Phase | NA |
Why NCT05293340 stopped before completion
NCT05293340 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).
The record links to 0 conditions, and to 1 intervention - of which Avocado Vouchers is the first listed.
NCT05293340 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05293340 about?
NCT05293340 is a clinical study titled "Continuous Glucose Monitoring and Hass Avocado Trial ("CHAT")". Hispanic/Latino adults in the United States (U.S.) bear a disproportionate burden of type 2 diabetes (T2D). Dietary changes, facilitated by increased access and adherence to healthy foods, are necessary. In this study, continuous glucose monitoring (CGM) will be used to quantify changes in glycemic ...
What is the current status of trial NCT05293340?
This trial is currently terminated. It is a NA study. The enrollment target is 50 participants. The study started on 2022-03-31. Estimated completion is 2023-01-31.
What interventions are being tested in trial NCT05293340?
The interventions under investigation include: Avocado Vouchers (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05293340?
This trial is sponsored by Sansum Diabetes Research Institute, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05293340's enrollment target sits among peer trials
50 1279th of 2000 higher than 622 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI